About
Technology
Issues
FAQ
Links
Official Page
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.